Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06613204

STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
640 (estimated)
Sponsor
Oregon Health and Science University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Accepted

Summary

The purpose of this nationwide study is to test STELLA-FTD (Support via Telehealth: Living and Learning with Advancing Alzheimer's Disease)-FTD, an intervention to specifically address the needs of family Care Partners of persons with frontotemporal degeneration (FTD). STELLA-FTD is a multicomponent videoconference-based intervention designed to facilitate effective use of community and peer resources to foster effective management of behavioral and psychological symptoms of dementia. The study is recruiting families from across the United States.

Detailed description

The study will enroll a total sample of up to 640 participants: 320 family Care Partners and their 320 Care Recipients with FTD. For our study "family Care Partner" includes any person who is considered "family" to the person with FTD, such as direct relations, fictive kin, close friends and neighbors. "Care Recipient" is defined as an individual with an FTD diagnosis noted by the AFTD: bv-FTD, PPA, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), or ALS with FTD. Care Recipients with FTD will not participate in intervention but will be consented (and thus enrolled) because data will be collected about them. The study will test to see if our program helps Care Partners. The STELLA-FTD intervention is delivered over 8 sessions within 10 consecutive weeks in 1-hour "live" video-based group sessions led by two guides. There will be two intervention groups, the control group and the test group. There will be up to 8 Care Partners per group, which allows for the development of mutual trust and commitment. Care Partners will be randomized to either the test or control group using an electronic randomization process and will be blinded to their group designation. Both groups will receive information and support (via videoconferencing). The test group will receive a different program than the control group. Care Partners will fill out 6 long surveys while in the study, and a brief weekly survey.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSTELLA-FTD ControlParticipants receive information about FTD and support via weekly group video-conference-based meetings.
BEHAVIORALSTELLA-FTD TestThe test group receives a information and support, but with a focus that is different from the Control Group

Timeline

Start date
2025-06-23
Primary completion
2029-06-01
Completion
2029-06-01
First posted
2024-09-25
Last updated
2025-10-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06613204. Inclusion in this directory is not an endorsement.